Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| St. Olavs Hospital | OTHER |
| Helse Midt-Norge | OTHER |
| Sykehusapotekene i Midt Norge | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Use of drugs is an important factor in secondary prophylaxis after transient ischemic attack (TIA), but studies show that adherence to the prescribed drugs is often poor. This randomised controlled trial aims to investigate whether a systematic follow up of drug treatment using medication reconciliation, medication reviews and patient counselling by clinical pharmacists, improves adherence and/or decreases cardiovascular events the first three months and the first year after TIA. Patient satisfaction will also be compared between the two groups.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| drug use counselling | Experimental | Pharmacist conducting drug reconciliation, medication reviews and drug use counselling during hospitalisation. Follow up telephone calls 1 week, 1 month, 2 months and three months after discharge from hospital |
|
| Control group | No Intervention | The patients in the control group receive no intervention just treatment and follow up according to national standards |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Drug use counselling | Behavioral |
|
| Measure | Description | Time Frame |
|---|---|---|
| adherence to drug treatment in secondary prevention after TIA | self reporting of adherence | 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| adherence to drug treatment in secondary prevention after TIA | self reporting of adherence | 1 year |
| Persistence | Persistence measured by control of filled prescriptions |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bent Indredavik, PhD, Prof | Norwegian University of Science and Technology | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ålesund Sykehus | Ålesund | Norway | ||||
| Kristiansund Sykehus |
Not provided
| ID | Term |
|---|---|
| D002546 | Ischemic Attack, Transient |
| D020521 | Stroke |
| D055118 | Medication Adherence |
| D010349 | Patient Compliance |
| ID | Term |
|---|---|
| D002545 | Brain Ischemia |
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 3 months |
| Incidence of stroke and cardiovascular events and deaths | Measured by using data from national health registries | 3 months |
| degree of disability or dependence in the daily activities | measured by modified Rankin Scale and indirectly by level of care | 3 months |
| patient satisfaction | Measured by using data from the Norwegian Stroke Registry | 3 months |
| Persistence | Persistence measured by control of filled prescriptions | 1 year |
| Incidence of stroke and cardiovascular events and deaths | Measured by using data from national health registries | 1 year |
| degree of disability or dependence in the daily activities | measured by modified Rankin Scale and indirectly by level of care | 1 year |
| patient satisfaction | Measured by using data from the Norwegian Stroke Registry | 1 year |
| Kristiansund |
| Norway |
| Levanger Sykehus | Levanger | Norway |
| Molde Sykehus | Molde | Norway |
| Namsos Sykehus | Namsos | Norway |
| St Olavs Hospital | Trondheim | Norway |
| D009422 | Nervous System Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D010342 | Patient Acceptance of Health Care |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
| D001519 | Behavior |